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ABSTRACT 
In the United States, 20,000 patients each year lose their sight from diabetic retinopathy. The cause has 
been attributed to a failure of control of glucose levels. Recent studies have challenged this, and have 
suggested that there is no evidence for a consistent glycemic threshold in various populations relating to 
the incidence of retinopathy. The Ehrlichia have been recently suggested as having a role in diabetes.  The 
action of this obligate parasitic bacterium which often affects the cells involved in immunity has the 
potential of affecting various tissues randomly.    This includes self-reactive T or B cells which may be 
erroneously altered or released from the marrow because of infection of marrow precursors by an 
Ehrlichia. The discovery of a gene obtained by molecular methodology from a leukemia patient, has given 
us a tool to identify by molecular methods, the presence of this gene and assumed bacterium in the blood 
of patients with various syndromes that includes diabetes. Because of the inconsistent evidence of a 
uniform glycemic threshold in retinopathy and the failure of its control, this hypothesis raises the question 
of something else that might be causing this damage.  The suspected bacterium in diabetes may have as a 
significant side effect of its infection of the immune system, specifically the site of action of damage to the 
small vessels of the retina which could lead to what is regularly described in retinopathy; further, and that 
may include damage to other vessels seen in peripheral and coronary arteries. The availability of a 
molecular test in whole blood specimens from diabetics suggests a survey for the gene of the bacterium 
described in diabetic patients and matched controls.  Such an investigation could lead to other therapies 
directed against the bacterium's presence in the marrow if discovered, and strategies to eliminate the 
harmful self-reactive T or B cells, if found in diabetes. 
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INTRODUCTION  
Diabetic retinopathy is a major cause of blindness in type 1 and 
2 diabetes. (1)  Damage to the retina in diabetes has long been 
attributed to failure of control of hyperglycemia and control of 
the glycemic abnormalities has been presented as the major 
way to prevent the onset of visual loss in both types of diabetes 
(2). A recent study raises questions about the orthodox view 
that glycemic abnormalities cause retinal damage. Wong et al., 
found inconsistent evidence of a uniform glycemic threshold for 
prevalent and incipient retinopathy, suggesting a discontinuity 
between cause and effect (3).   This finding raises the question 
of what else might be causing retinal damage in diabetes. 
Ehrlichia are little-known and poorly understood obligate 
parasitic intracellular bacteria.   Most published data on these 
bacteria concentrate on the two known agents, believed to be 
common in rodents, which have been successfully cultured 
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from the blood of patients suffering from acute Ehrlichiosis, 
following from infection transmitted by ticks.   This group is 
now being expanded (4). 
 The Anaplasma are a closely related group of organisms.  For 
purposes of clarity in this paper, they will be referred to 
collectively henceforth as the EA.   
 A publication in the Journal of Medical Hypotheses last year by 
this author introduced the possibility of EA infection of immune 
system cells, particularly those governing the activity of 
lymphocytes, and a number of serious disease states of 
otherwise unknown etiology that might be caused by this 
condition(5). This author has proposed that another, 
heretofore unknown Erhlichial agent—tentatively identified by 
a gene 97% coincident with the major surface protein from 
Anaplasma phagocytophillium (a member of the EA family)—
causes chronic infection in humans, capable of producing many 
of the features and complications of diabetes, including 
retinopathy.      
 
HYPOTHESES 
I hypothesize that in the absence of conclusive proof that 
glycemic abnormalities cause diabetic retinopathy, another 
cause -infection with EA- could explain the vascular and 
neurologic changes in the retina of diabetic patients   
Malfunction of the human immune system caused by EA could 
induce changes affecting T or B cells, with a direct cellular effect 
on the retinal vessels or the possible indirect effect of self-
reactive B cells producing antibodies against specific tissue in 
the retinal vessels. 
 
Supportive data 
The function of the bone marrow and relationship to occult 
infection 
The basic study of the immune system, including the 
metamorphosis from stem cells to the cells of immunity, is not 
at present a major area of interest of ophthalmologists.  
Making the connection hypothesized here requires some 
knowledge of the construction of lymphocytes, the major agent 
of cellular and antibody immunity within the bone marrow.   
From the stem cell there is a rapid proliferation of lymphocytic 
and myelocytic cells of immunity. The active cells are 
reconstituted by marrow mechanisms using fragments of DNA. 
This reconstruction is random.  Approximately 60% of such cells 
are directed against body tissues, thus these are self-reactive.  
Before release from the marrow, several regulatory 
mechanisms within the marrow normally eliminate the self-
reactive cells. (6.) 
One infection that may change the function of the immune 
system 
EA produce a substance intracellularly, named host 
transcription protein (HTP). This substance is used by the EA to 
change its intracellular environment to foster and assist the 
parasite’s growth, development and reproduction. The 
untoward effect of HTP may affect the reproductive activity of 
the rapidly proliferating cells in the marrow.  
The impact of HTP on the intracellular environment of the 
proliferating marrow cells has been shown in some 
experiments to affect the nuclear instructions from the parent 
cell to the daughter cell.  These abnormalities may include 
transcription errors, mutations, and errors of immune cell 
development (7). Cascading impacts from these transcription 
errors could result in production of self-reactive antibodies, 
failure of scheduled apoptosis and/or non-scheduled apoptosis 
of immune cells, and deficiencies in the development or ratios 
of particular immune system components.    The presence and 
activity of these self-reactive and malfunctioning immune 
system cells could cause many and varied human pathologies, 
including the pathophysiology of diabetic retinopathy. 
 
Changes in marrow cells and their possible relationship with 
pathological changes in diabetes, including retinopathy 
Unsuspected impacts from malfunctioning immune system cells 
could impact the mechanical properties and permeability of the 
retinal blood vessels, leading to the formation of micro 
aneurysms, retinal hemorrhages, micro retinal infarcts, and in 
the nerve fiber layer of the retina, deposit cotton wool patches 
(7).  Other known consequences of diabetes are only connected 
to the hyperglycemic state with difficulty, and not conclusively 
proved.  These include diabetic nephropathy (Kimmelstiel-
Wilson nephropathy) Small vessel disease in the lower 
extremities and changes in the vascular structure of smaller and 
larger arterial structures such as the coronary arteries could 
lead to these other manifestations of the pathology of 
diabetes(8).  
An interesting correlation is presented by other unexplained 
problems in the diabetic.  The small vessel retinal problems of 
basement membrane thickening, including micro-aneurysms, 
and pre-retinal neovascularization , which leads to the eventual 
loss of vision-- is mirrored by  other lesions of diabetes, 
especially in the diabetic foot.  The presence of poor circulation 
in the lower extremities, with gangrene, repetitive infections 
leading to amputations and an eventual 30% mortality all occur 
in the lower extremities often with little evidence of large 
vessel disease. The hypothesis presented here suggests that the 
basic cause in both of these manifestations could come about 
because of self-reactive antibodies or cells, which attack a 
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specific component needed by the small blood vessels for 
maintenance of competence.   This same process could also be 
at work in the microvasculature of the pancreatic islet cells, 
which cease to function properly in diabetes. 
The hypothesis of a single cause occurring at the molecular 
level offers a better explanation for diabetes.  Scientists have 
concentrated on the fluctuating glucose level in diabetic but 
that may not explain the disease states, especially since the 
glucose level has been effectively challenged as causative of 
retinopathy. 
 
 
 
 
 
 
 
 
 
 
Figure 1 
The cascade of the development of the blood cells, including those 
responsible for immunity, from the stem cell to the active circulating 
cells of the blood 
Human stem cells (HCS) can progress via two major changes to lymphocytic and 
myelocytic cells. This schematic chart of the functions of the proliferating cells of 
the bone marrow is indeed remote from the daily considerations of 
ophthalmologists. In active proliferation of the cells from the bone marrow, which 
occurs on a daily basis and replaces all of the erythrocytes in the body every 120 
days, creates the final cells of immunity especially the T and B cells. These can 
alter or eliminate the activities of other cells, and the understanding of this basic 
process is essential when considering the possible activity of Ehrlichia in altering 
this process (From the Journal of Medical Hypotheses; 77:374-379; 2011). 
 
Figure 2. 
The identification of the sequences described previously from a 
leukaemia patient’s blood when subjected to PCR which was found to 
be approximately 97% homologous to the identified major surface 
protein [MSP2] of Anaplasma phagocytophillium [5]. Sybr 8_5R.seq: DNA 
preparation 8 (5 µl) with the Reverse primer as the sequencing primer 
Sybr 1_5R.seq: DNA preparation 1 (5 µl) with the Reverse primer as the 
sequencing primer, Sybr 1_5F.seq: DNA preparation 1 (5 µl) with the Forward 
primer as the sequencing primer, Sybr 8_5F.seq: DNA preparation 8 (5 µl) with 
the Forward primer as the sequencing primer, Sybr 8 F.seq: DNA preparation 8 (1 
µl) with the Forward primer as the sequencing primer, Sybr1F.seq: DNA 
preparation 1 (1 µl) with the Forward primer as the sequencing primer, HE 
amplicon.seq: Represents the deposited sequence for Anaplasma 
phagocytophillium amplified with the Reverse primer, Red T’s and A’s denote the 
area of divergence of the unknown strain to the positive sequence.   This PCR 
reaction will result in a 70 bp region that can be used for sequencing. In this 
schematic representation familiar to molecular biologists, explanation is 
necessary for those not familiar with this highly specialized form of molecular 
biology. The numbers at the top of the chart represent the position of the 
standard E Coli used as a reference for bacteria. The extreme bottom part of the 
chart which is in small non-capitalized letters is the deposited sequences from the 
BLAST program (HGE is the older nomenclature of human granulocytic Ehrlichia). 
This has been reported in the BLAST record, and deposited as those found in 
Anaplasma phagocytophillium (AP). The second line in the chart is the 
consensuses of those proceeding from the examination of the PCR are from a 
patient with leukemia.  Two aberrations from the sequences of MSP2 of AP occur 
at numbers 591 and a smaller number at 578.  An interpretation of these data 
suggests that there is indeed a difference from the major surface protein of AP, 
and the PCR product was obtained from a human patient with myelocytic 
leukemia. The publication with this data was first presented suggested that the 
sequences of this result represented a gene found is a pathogen in a human 
patient with a disease of the immune system specifically, leukemia. The use of the 
sequences when applied with the proper development of probes and primers 
could identify the presence or absence of this gene in the whole blood of patients 
especially diabetics with retinopathy.  A statistical analysis of such examination if 
positive and statistically confirmed gives the ophthalmologists and investigators 
rationale and tools for intervention to eliminate the presumed invaders of the 
immune system in the patient.  Conclusions derived from these studies could lead 
to appropriate interventions including antibiotics and other maneuvers to change 
the immune response which might include marrow transplantation. (From the 
Journal of Medical Hypotheses; 77:374-379; 2011). 
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DISCUSSION 
Wong et al. [3] offered a major challenge to the widely 
accepted view that hyperglycaemia is a definitive factor in 
diabetic retinopathy. If this group is correct, one must look for 
another explanation. The hypothesis described in this paper 
offers alternative mechanisms for inducing these changes at 
the molecular level, either by antibodies or self-reactive T cells 
directed against components of the retinal vasculature.   
The mechanism explained in detail here offers a pathologic 
mechanism by which infection at the stem cell level leads to the 
unobvious remote changes in the micro-vasculature of the 
retinal vessels.  This hypothesis, if confirmed, could not have 
been imagined without studying whether or not the infection is 
present in two groups: diabetic retinopathy or all diabetes. The 
hypothesis presented here and in the previous paper discussing 
Ehrlichia and the immune system presents a fertile ground for 
investigation. Indeed, the bankruptcy of preconceived and 
believed thought suggested in the Lancet revision should be a 
spur to investigate all possibilities [3].   
The sequences of MSP2 that differ from those of AP only at two 
nucleotides appear to represent the discovery of the gene by 
molecular methodologies in the whole blood of patients, rather 
than in controls.  These published and in press accounts offer a 
method of diagnosis to determine whether the suspected 
bacterium is present or absent. Such a simple study could 
reveal an alternative explanation for the great malady which 
afflicts approximately 20,000 diabetics in the United States 
each year with blindness.  If it is found that patients with 
diabetic retinopathy have the bacteria using the precise 
diagnosis of molecular methodology, yet controls do not, 
various studies could and should be devised to see if 
interventions can alter the course of diabetic retinopathy. 
Further knowledge must first be obtained to determine 
whether the defect is in T cells or B cells or both. Interventions 
will become easier if that information is obtained, and this 
could be easily discovered. The possible interventions if the 
presence of the pathogen is confirmed would include antibiotic 
therapy and/or stem cell replacement with marrow transplants. 
 
CONCLUSION 
It is axiomatic that if an interpretation of data suggests a 
pathological process, and the suggested treatment of that 
interpretation of data fails to provide a satisfactory explanation 
of why that treatment has failed, that a re-examination of the 
entire process is mandated.  This alternative explanation should 
be considered and tested. 
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